Literature DB >> 20198794

[Evaluation of mammography and risk of developing breast cancer in patients with ovarian or endometrial cancer].

H Ietimalar, A Koksal, N Chelik, B Kasap, K Chukurova, A Iuldarum.   

Abstract

AIM: In this study our aim is to evaluate the reproductive factors determining the risk for breast cancer and the mammographical density in patients with ovarian or endometrial carcinoma.
MATERIALS AND METHODS: 24 patients with epithelial ovarian carcinoma and 35 patients with endometrial adenocarcinoma who were hospitalized at Izmir Ataturk Training and Research Hospital between the dates of May 2005 and June 2006 for diagnosis, treatment and follow-up were included to our study. The control group was formed with 25 healthy women of over 40 years of age applied to our mammography unit for routine screening. All patients were questioned by means of reproductive risk factors for breast cancer. Mammographical images were gained in two projections as craniocaudal and mediolateral. Mammographical images were evaluated by using BI-RADS scoring system in terms of density and by one radiologist. Plasma E2 levels were taken from all postmenaupausal patients.
RESULTS: Mean age was higher in patients with endometrial carcinoma. The age of menarche was higher in patients with ovarian carcinoma. There were no significant differences between the groups in terms of age of menaupose, age of first delivery, lactation and duration of lactation, HRT use and incidence of type-2 diabetes. No any significant difference was detected in terms of E2 levels and mammographical density. DISCUSSION: Reproductive risk factors for breast cancer in patients with ovarian and endometrial carcinoma were not different from the healthy population. The results of our study didn't reflect the reported increased risk rates for breast cancer.

Entities:  

Mesh:

Year:  2009        PMID: 20198794

Source DB:  PubMed          Journal:  Akush Ginekol (Sofiia)        ISSN: 0324-0959


  1 in total

1.  Comparison of diagnostic values between CA125 combined with CA199 and ultrasound combined with CT in ovarian cancer.

Authors:  Bingcheng Guo; Wei Lian; Shuai Liu; Yingchun Cao; Jianhua Liu
Journal:  Oncol Lett       Date:  2019-04-18       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.